Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 42 Neoplasms 6 Neoplasm Metastasis 4 Colorectal Neoplasms 4 Adenocarcinoma 3 Resectable Pancreatic Cancer 2 Rectal Neoplasms 2 Pancreatic Cancer Metastatic 2 Carcinoma, Hepatocellular 2 Biliary Tract Neoplasms 2 Urachal cancer 1 Stomach Neoplasms 1 Pancreatic Ductal Adenocarcinoma (PDAC) 1 Pancreatic Cancer Non-resectable 1 Pancreatic Adenocarcinoma 1 Neoplasms, Basal Cell 1 Locally Advanced Unresectable or Metastatic Solid Tumors 1 Localized Pancreatic Adenocarcinoma 1 Gastrointestinal Neoplasms 1 Gastroesophageal Adenocarcinoma 1 Gastro-enteropancreatic neuroendocrine tumor 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Cancer Metastatic 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Pancreatic Ductal 1 Carcinoma, Islet Cell 1 Carcinoma 1 Borderline Resectable Pancreatic Cancer 1

Interventions

Gemcitabine 111 Cisplatin 75 Oxaliplatin 43 pembrolizumab 34 Fluorouracil 31 Capecitabine 30 durvalumab 26 Leucovorin 25 lenvatinib 23 Magnetic Resonance Spectroscopy 14 Irinotecan 13 Nivolumab 12 Albumin-Bound Paclitaxel 12 Specimen Handling 11 Radiofrequency Ablation 11 Drug Therapy 11 Biopsy 11 tislelizumab 10 pemigatinib 10 apatinib 10 Taxes 10 Floxuridine 10 130-nm albumin-bound paclitaxel 10 Radiotherapy 9 Bevacizumab 9 Folfox protocol 8 Carboplatin 8 tremelimumab 7 atezolizumab 7 S 1 (combination) 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Cholangiocarcinoma × folfirinox × Clear all

NCT02456714 2020-03-10

4CC

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 2 Completed

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡